StemCellAtlasPowered by Stem Plus Clinic · Sofia, EU Get matched with the clinic
☰
Treatments Cell therapies Who we help Costs Cost calculator Data Guides Journal Get matched with the clinic
Home › Journal
Journal

Journal

Stem cell therapy cost by country (2026): sourced comparison

Read the 2026 insight.

Open →

Stem cell therapy cost in the EU — 2026 breakdown

Read the 2026 insight.

Open →

Bulgaria vs Germany: stem cell cost compared

Read the 2026 insight.

Open →

Why US patients travel abroad for stem cell therapy

Read the 2026 insight.

Open →

Mesenchymal stem cells (MSCs), explained simply

Read the 2026 insight.

Open →

Exosomes vs stem cells — what's the difference?

Read the 2026 insight.

Open →

Stem cell success rates: how to read the numbers

Read the 2026 insight.

Open →

Where the autism cell-therapy evidence stands in 2026

Read the 2026 insight.

Open →

MS and regenerative medicine: the 2026 picture

Read the 2026 insight.

Open →

European quality without European prices — how it works

Read the 2026 insight.

Open →

The travel cost most clinics never show you

Read the 2026 insight.

Open →

A Gulf patient's guide to cell therapy in the EU

Read the 2026 insight.

Open →

Safety first: questions to ask any clinic

Read the 2026 insight.

Open →

Cell-based anti-ageing: hype vs reality

Read the 2026 insight.

Open →

Cell therapy for knees and joints: cost & results

Read the 2026 insight.

Open →

The diabetes cell-therapy frontier in 2026

Read the 2026 insight.

Open →

Regenerative medicine for men's health, discreetly

Read the 2026 insight.

Open →

Which cell type is right for your condition?

Read the 2026 insight.

Open →

How remote follow-up works after treatment abroad

Read the 2026 insight.

Open →

Why we publish our prices when others hide them

Read the 2026 insight.

Open →

A patient's first-visit diary: Sofia week

Read the 2026 insight.

Open →

Sofia rising: why Bulgaria's capital is booming

Read the 2026 insight.

Open →

Bulgaria's medical sector in 2026: faster, modern, EU-grade

Read the 2026 insight.

Open →

The air that heals: Bulgaria's climate and recovery

Read the 2026 insight.

Open →

800 mineral springs: Bulgaria's balneology advantage

Read the 2026 insight.

Open →

Why 'stem cell abroad' searches tripled since 2023

Read the 2026 insight.

Open →

Orthopaedics: the fastest-growing cell-therapy demand

Read the 2026 insight.

Open →

Neurology's regenerative frontier in 2026

Read the 2026 insight.

Open →

From the Gulf to the EU: why families choose Bulgaria

Read the 2026 insight.

Open →

Beating the wait: UK patients and regenerative medicine

Read the 2026 insight.

Open →

The FDA gap: why Americans look abroad

Read the 2026 insight.

Open →

From €30k to €6k: the German price-shock explained

Read the 2026 insight.

Open →

China & East Asia patients: the EU option

Read the 2026 insight.

Open →

How much you save by condition: the data

Read the 2026 insight.

Open →

The hidden cost of waiting for treatment

Read the 2026 insight.

Open →

Exosomes in 2026: where cell-free therapy is heading

Read the 2026 insight.

Open →

The longevity boom and regenerative medicine

Read the 2026 insight.

Open →

Cell-based hair restoration: what works

Read the 2026 insight.

Open →

Cell therapy vs knee replacement: the trade-offs

Read the 2026 insight.

Open →

The price-transparency movement in medical tourism

Read the 2026 insight.

Open →

How we vet every protocol before offering it

Read the 2026 insight.

Open →

What international patients tell us matters most

Read the 2026 insight.

Open →

Bulgaria in the EU since 2007: what it means for you

Read the 2026 insight.

Open →

The ideal recovery week in Bulgaria

Read the 2026 insight.

Open →

Five myths about stem cell therapy abroad

Read the 2026 insight.

Open →

12 questions to ask before booking anywhere

Read the 2026 insight.

Open →

Compare cell-therapy evidence, registered studies and published price observations.

StemCellAtlas is a source-first research and cost-planning guide. It separates registry and regulator evidence from heterogeneous commercial observations.

Get an honest assessment